- $27.45bn
- $29.25bn
- $1.51bn
- 98
- 15
- 81
- 70
2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,160 | 1,295 | 1,317 | 1,377 | 1,514 |
Cost of Revenue | |||||
Gross Profit | 823 | 933 | 984 | 1,075 | 1,203 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 907 | 999 | 811 | 835 | 871 |
Operating Profit | 254 | 296 | 505 | 542 | 643 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 216 | 257 | 473 | 471 | 554 |
Provision for Income Taxes | |||||
Net Income After Taxes | 192 | 236 | 392 | 374 | 429 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 192 | 236 | 392 | 374 | 429 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 192 | 236 | 392 | 374 | 429 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 6.34 | 9.28 | 10.8 | 14.2 | 16.9 |